The goal of the Monotherapy Dose Escalation phase (Part 1) of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tum…

Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more

~Estimated

~$10 – $8,750

NiKang Therapeutics, Inc.NCT06586957

Phase 1

Phase I Study of 5-Azacitidine Plus PD-1/PD-L1 Inhibitor in Patients With PD-1/PD-L1 Refractory Tumors

This is a Phase I study to determine the optimal biological dose (OBD) of 5-Azacitidine in combination with PD-1/PD-L1 inhibitors in patients with tumors refra…

Solid TumorLocally Advanced Solid TumorMetastatic Tumor

~Estimated

~$10 – $7,500

Mohammed MilhemNCT07404332

Phase 2

A Phase II Study Evaluating Definitive Radiosurgical Decompression in Patients With High-Risk Spinal Metastases

This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only an…

Metastatic CancerMetastatic Lung CancerMetastatic Breast Cancer+5 more

~Estimated

~$10 – $6,250

Stony Brook UniversityNCT06165419